Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).
暂无分享，去创建一个
A. Dutt | Rajiv Kumar | A. Mahajan | K. Prabhash | V. Noronha | V. Patil | A. Joshi | N. Purandare | S. Banavali | Akanksha Yadav | A. Chougule | A. Janu | Vaishakhi Trivedi | S. Goud | S. More | Srushti Shah | Vichitra Behel | N. Kadam | Nilesh Daware